Skip to main content
Equibles

BARCLAYS PLC

Position in VCEL — Vericel Corp

CIK 312069 LONDON, X0
Back to VCEL Full portfolio

Position in VCEL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,235,667
+$1,405,550 QoQ
Shares Held
72,728
+27.8% QoQ
Ownership
0.142%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#84
of 317 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VCEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,600 across 455 Biotechnology names. VCEL ranks #51 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in VCEL

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,235,667 72,728
2026-03-31 $1,830,117 56,889
2025-12-31 $5,676,039 157,624
2025-09-30 $5,030,415 159,848
2025-06-30 $6,840,422 160,762
2025-03-31 $4,172,103 93,503
2024-12-31 $6,042,625 110,046
2024-09-30 $4,712,015 111,527
2024-06-30 $2,085,016 45,445
2024-03-31 $3,287,299 63,193
2023-12-31 $4,508,581 126,610
2023-09-30 $7,106 212
2023-06-30 $1,007,627 26,820
2023-03-31 $1,759 60
2022-09-30 $2,303,620 99,294
2022-06-30 $369,541 14,676
2022-03-31 $1,440,854 37,699
2021-12-31 $2,416,517 61,489
2021-09-30 $3,037,409 62,242
2021-06-30 $2,358,247 44,919
2021-03-31 $5,041,328 90,753
2020-12-31 $2,221,136 71,928
2020-09-30 $2,027,274 109,405
2020-06-30 $427,728 30,950
2020-03-31 $172,533 18,815